Strategy Unit Homepage

Main navigation

Global Heath: Background Papers

• Working Paper: The situation and existing action to combat HIV/AIDS, TB, and malaria in developing countries.  (pdf, 79kb)
• CPI Paper: Forging a commitment: Tackling the diseases of poverty. Annex. (pdf, 72kb)
• Cost Effectiveness of various methods of encouraging development of vaccines against HIV/AIDS, malaria, and TB : an analysis prepared for the PIU, by Michael Kremer, Professor of Economics, Havard University, and Senior Fellow, Brookings Institution.
• Executive Summary: Cost effectiveness of various methods of encouraging development of vaccines against HIV-AIDS, malaria, and TB: An analysis prepared for the PIU. (pdf, 20kb)
• Appendix One: Estimating the current and necessary market to spur research for HIV/AIDS, malaria, and TB (pdf, 35kb)
• Appendix Two: The advantages and disadvantages of each of the policy instruments (pdf, 64kb)
• Appendix Three: A model to compare policy instruments to stimulate research and development on new products (pdf, 98kb)
• Appendix Four: A vaccine purchase commitment: preliminary cost-effectiveness estimates and pricing guidelines (pdf, 240kb)
• Appendix Five: Addressing the access issue in the development of vaccines for HVI/AIDS, malaria, and TB. (pdf, 51kb)
• Appendix Six: Creating markets for new vaccines. Part I - Rationale (pdf, 102kb)
• Appendix Seven: Creating markets for new vaccines. Part II - Design Issues (pdf, 130kb)
• Appendix Eight: Stimulating R&D on neglected diseases: problems with an enhanced research and development tax credit (pdf, 14kb)
• Appendix Nine: A patent policy proposal (pdf, 66kb)
• Appendix 10: Comparing the drug case spreadsheet with the vaccine cost effectiveness spreadsheet (pdf, 22kb)
• Appendix 11: Notes on the spreadsheets that analyse purchase commitments for existing technologies  (pdf, 22kb)